To comprehensively understand these three lncRNAs (BOLA3-AS1, AC124067.4, and AL161772.1) and four target RNAs (NINL, SALL4, TNFSF11, PHYHIPL), we performed differential expression, cancer stemness, immune subtype, TME infiltration, and drug sensitivity analyses. Here, BOLA3 is linked to cancer.